Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review
- PMID: 29580147
- PMCID: PMC6300339
- DOI: 10.1080/15384047.2018.1456600
Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review
Abstract
Advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy and surgery followed by early brain metastasis is rare. A 52-y-old male patient who was diagnosed with advanced gastric cancer (cT4N2M0, stage ШB). Radiological examinations after three cycles of preoperative chemotherapy with a modified FOLFOX6 (mFOLFOX6) regimen showed a partial response (PR) had been achieved. The patient underwent curative surgery consisting of proximal gastrectomy, and D2 lymph node dissection. The lack of abnormal gastric cancer cells in the primary lesion or lymph nodes confirmed a pathological complete response (pCR). Postoperative chemotherapy with oral S-1 was administrated. However, during the second cycles of postoperative chemotherapy, the patient experienced headaches, projectile vomiting and convulsion. Upon further examination, a tumor representing metastasis to the brain was recognized by cranial enhanced magnetic resonance imaging (MRI) examination and cytopathology of cerebrospinal fluid. In addition to documenting the case report, we reviewed the literature associated to features of metastatic brain malignancies that form from gastric cancer. In short, advanced gastric cancer patents achieved pCR after preoperative chemotherapy typically have good prognosis; however, great attention should be paid on detecting metastatic events.
Keywords: brain metastasis; gastric cancer; pathological complete response; preoperative chemotherapy.
Figures



Similar articles
-
[Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Oct 25;20(10):1168-1173. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 29130233 Chinese.
-
Histological complete response after neoadjuvant XELOX in advanced gastric carcinoma.Hepatogastroenterology. 2013 May;60(123):638-40. doi: 10.5754/hge121131. Hepatogastroenterology. 2013. PMID: 23340232 Review.
-
[Histological complete response in a case of advanced gastric cancer treated by neoadjuvant TS-1 combined with CDDP therapy].Gan To Kagaku Ryoho. 2011 Jan;38(1):101-4. Gan To Kagaku Ryoho. 2011. PMID: 21368467 Japanese.
-
[A Case of Stage IV Gastric Cancer Which Showed Pathological Complete Response after Neo-Adjuvant Chemotherapy].Gan To Kagaku Ryoho. 2018 Apr;45(4):667-669. Gan To Kagaku Ryoho. 2018. PMID: 29650829 Japanese.
-
[A case of advanced gastric cancer responding to S-1/CDDP neoadjuvant chemotherapy, leading to a pathological complete response].Gan To Kagaku Ryoho. 2015 Jan;42(1):85-7. Gan To Kagaku Ryoho. 2015. PMID: 25596685 Review. Japanese.
Cited by
-
The Role of Neoadjuvant Therapy in a Giant Gastric Gastrointestinal Stromal Tumour: A Case Report and Review of the Literature.Cureus. 2024 Mar 6;16(3):e55655. doi: 10.7759/cureus.55655. eCollection 2024 Mar. Cureus. 2024. PMID: 38586745 Free PMC article.
-
Brain metastasis from gastric adenocarcinoma: A large comprehensive population-based cohort study on risk factors and prognosis.Front Oncol. 2022 Oct 18;12:897681. doi: 10.3389/fonc.2022.897681. eCollection 2022. Front Oncol. 2022. PMID: 36338733 Free PMC article.
References
-
- Yu M, Zheng HC, Xia P, Takahashi H, Masuda S, Takano Y, Xu HM. Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res. 2010;132:295–302. PMID:20847376. - PubMed
-
- Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20. doi:10.1056/NEJMoa055531. PMID:16822992. - DOI - PubMed
-
- Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, et al.. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715–21. doi:10.1200/JCO.2010.33.0597. PMID:21444866. - DOI - PubMed
-
- Cho H, Nakamura J, Asaumi Y, Yabusaki H, Sakon M, Takasu N, Kobayashi T, Aoki T, Shiraishi O, Kishimoto H, et al.. Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol. 2015;22:787–92. doi:10.1245/s10434-014-4084-9. PMID:25223927. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials